A phase I-II study with carboplatin (C) and weekly paclitaxel (P) in advanced NSCLC

被引：0
|
作者：
Fabi, A
Barduagni, M
De Marco, S
De Marinis, F
Cortesi, E
Foggi, CM
Chiapparino, E
Gareri, R
Venturoli, AL
Cognetti, F
机构：
[1] Regina Elena Canc Inst, Div Med Oncol 1, Rome, Italy
[2] Forlanini Hosp, Div Pneumol, Rome, Italy
[3] Univ Rome La Sapienza, Oncol Serv, Rome, Italy
[4] San Filippo Neri Hosp, Div Oncol, Rome, Italy
[5] Bristol Myers Squibb, Rome, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81469-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1049
引用
收藏
页码：S263 / S264
页数：2
相关论文
共 50 条
  • [41] Phase II trial of cetuximab (C225) in combination with monthly carboplatin (Cb) and weekly paclitaxel (Pac) in patients with advanced NSCLC: Promising early results
    Langer, Corey J.
    Ruth, Karen
    Borghaei, Hossein
    Treat, Joseph A.
    Shafer, Danielle
    Millenson, Michael
    Tuttle, Holly
    Rovito, Marc
    Mintzer, David
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S465 - S466
  • [42] Phase II trial of cetuximab (C225) in combination with monthly carboplatin (Cb) and weekly paclitaxel (Pac) in patients with advanced NSCLC: Promising early results
    Borghaei, H.
    Langer, C. J.
    Millenson, M.
    Tuttle, H.
    Seldomridge, J.
    Rovito, M.
    Mintzer, D.
    Treat, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Weekly paclitaxel (P), carboplatin (C) and irinotecan (I), PCI, in patients with chemo-naive advanced non-small cell lung cancer (NSCLC)
    Chang, A
    LUNG CANCER, 2005, 49 : S240 - S240
  • [44] Phase I/II trial of paclitaxel (P), carboplatin (C), and irinotecan (CPT-11) in advanced, metastatic non-small cell lung cancer (NSCLC)
    Socinski, MA
    Miller, LL
    Sandler, AB
    Israel, VK
    Hanover, CK
    Locker, PL
    Elfring, GL
    Natale, RB
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 23 - 23
  • [45] A PHASE I-II STUDY OF DASATINIB (D) IN COMBINATION WITH WEEKLY (W) PACLITAXEL (P) FOR PATIENTS (PTS) WITH METASTATIC BREAST CARCINOMA (MBC)
    Fornier, M. N.
    Morris, P. G.
    Abbruzzi, A.
    D'Andrea, G.
    Gilewski, T.
    Lake, D.
    Norton, L.
    Chang, J.
    Hudis, C.
    ANNALS OF ONCOLOGY, 2010, 21 : 110 - 110
  • [46] Phase I study of nivolumab (nivo) plus nab-paclitaxel (nab-P) plus carboplatin (C) in advanced NSCLC: safety and efficacy results
    Waterhouse, David M.
    George, Ben
    Gutierrez, Martin
    Otterson, Greg A.
    Ko, Amy
    Ong, Teng Jin
    Stergiopoulos, Sotirios
    Trunova, Nataliya
    Kelly, Karen
    CANCER RESEARCH, 2016, 76
  • [47] Phase II multicenter trial of a weekly paclitaxel and carboplatin regimen in patients with advanced breast cancer
    Loesch, D
    Robert, N
    Asmar, L
    Gregurich, MA
    O'Rourke, M
    Dakhil, S
    Cox, E
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) : 3857 - 3864
  • [48] Phase II trial of weekly paclitaxel and carboplatin chemotherapy in patients with advanced transitional cell cancer
    Johannsen, M
    Sachs, M
    Roigas, J
    Hinke, A
    Staack, A
    Loening, SA
    Schnorr, D
    Wille, AH
    EUROPEAN UROLOGY, 2005, 48 (02) : 246 - 251
  • [49] Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study
    Stathopoulos, GP
    Rigatos, SK
    Christodoulou, C
    Malamos, NA
    Deliyiannis, F
    Stathopoulos, JG
    Skarlos, DV
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (03) : 259 - 264
  • [50] Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study
    George P. Stathopoulos
    Sotiris K. Rigatos
    Christos Christodoulou
    Nikos A. Malamos
    Filippos Deliyiannis
    John G. Stathopoulos
    Dimosthenis V. Skarlos
    Cancer Chemotherapy and Pharmacology, 2004, 54 : 259 - 264
12345